Cancer Clinical Trials in Dallas, Texas

12 studies are recruiting for cancer in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Connect for Cancer Prevention Study (Connect)

   Background: The National Cancer Institute, part of the National Institutes of Health, has partnered with nine health care systems across the U.S. to establish the Connect for Cancer Prevention Study. While researchers have made important discoveries, there is more to learn to lower the number of pe…

   Stage

   Not phased

   Ages

   30 to 70

   Site

   Baylor Scott and White Health, Dallas, Texas

   Locations

   10 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT04609072 on ClinicalTrials.gov

2. Falcon Real World Evidence Registry

   This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.

   Stage

   Not phased

   Ages

   50 to 80

   Site

   Baylor Scott & White Health, Dallas, Texas

   Locations

   2 in total

   Run by

   Exact Sciences Corporation

   See if you can join NCT06589310 on ClinicalTrials.gov

3. Abatacept in Immune Checkpoint Inhibitor Myocarditis

   The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI). The primary outcome, MACE, is a composite of first occurren…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   University of Texas Southwestern, Dallas, Texas

   Locations

   31 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT05335928 on ClinicalTrials.gov

4. Pan Tumor Rollover Study

   Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Local Institution, Dallas, Texas

   Locations

   399 in total

   Run by

   Bristol-Myers Squibb

   See if you can join NCT03899155 on ClinicalTrials.gov

5. Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

   To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii)…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Liver Center of Texas, Dallas, Texas

   Locations

   7 in total

   Run by

   Helio Genomics

   See if you can join NCT05181826 on ClinicalTrials.gov

6. Childhood Cancer Survivor Study

   The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximate…

   Stage

   Not phased

   Ages

   Any age

   Site

   University of Texas Southwestern Medical Center, Dallas, Texas

   Locations

   31 in total

   Run by

   St. Jude Children's Research Hospital

   See if you can join NCT01120353 on ClinicalTrials.gov

7. Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation

   Registry database repository for determining clinical outcomes primarily of patients who have received or have been evaluated for radiation treatment in either the definitive or palliative setting for both malignant and benign etiologies. To compare the outcomes with National Cancer Data Base (NCDB…

   Stage

   Not phased

   Ages

   18 to 99

   Site

   UT Southwestern Medical Centre, Dallas, Texas

   Run by

   University of Texas Southwestern Medical Center

   See if you can join NCT03617237 on ClinicalTrials.gov

8. A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

   The goal of this clinical trial is to test CPO301, a type of drug called an antibody drug conjugate in adult patients with advanced or metastatic solid tumors. The main questions it aims to answer are: * To assess the safety and tolerability of CPO301 at increasing doses and determine the dose to b…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   NEXT Dallas, Dallas, Texas

   Locations

   14 in total

   Run by

   Conjupro Biotherapeutics, Inc.

   See if you can join NCT05948865 on ClinicalTrials.gov

9. The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.

   The purpose of the Texas Immuno-Oncology Biorepository (TIOB) is to collect and store well-defined and well-annotated serial biospecimens of tissue, blood, urine and stool in a longitudinal manner from cancer patients who are receiving either standard of care surgical interventions and or FDA appro…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Baylor University Medical Center - Dallas, Dallas, Texas

   Locations

   8 in total

   Run by

   Baylor Research Institute

   See if you can join NCT05371756 on ClinicalTrials.gov

10. A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors

    The goal of this clinical trial is to test JMT108, a type of drug called a bispecific antibody in adult patients with locally advanced or metastatic solid tumors. The main questions it aims to answer are: * To assess the safety and tolerability of JMT108 at increasing doses and determine the dose a…

    Stage

    Phase 1

    Ages

    18 and older

    Site

    NEXT Dallas, Dallas, Texas

    Locations

    3 in total

    Run by

    Conjupro Biotherapeutics, Inc.

    See if you can join NCT07317505 on ClinicalTrials.gov

11. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

    Stage

    Not phased

    Ages

    Any age

    Site

    Massive Bio SYNERGY-AI site, Dallas, Texas

    Locations

    68 in total

    Run by

    Massive Bio, Inc.

    See if you can join NCT03452774 on ClinicalTrials.gov

12. Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System

    The purpose of this prospective cohort study is to assess clinical and quality of life measures as well as to define the severity of adverse effects for the use of the RefleXion system to deliver intensity-modulated radiotherapy (IMRT), stereotactic body radiotherapy (SBRT), or SCINTIX Biology-guid…

    Stage

    Not phased

    Ages

    Any age

    Site

    UT Southwestern, Dallas, Texas

    Locations

    5 in total

    Run by

    RefleXion Medical

    See if you can join NCT05406167 on ClinicalTrials.gov